| RS1557917535 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS1557917899 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS1557918544 |
GNAT2
|
Health Risk |
Likely pathogenic |
Achromatopsia 4, Retinal dystrophy |
| RS1557918619 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Cone dystrophy |
| RS1557918635 |
GNAT2
|
Health Risk |
Likely pathogenic |
Achromatopsia 4, Retinal dystrophy |
| RS1557918638 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia |
| RS1557918911 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS1557920291 |
GNAT2
|
Health Risk |
Pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS1557932876 |
COL11A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS1557935477 |
POGZ
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1557943002 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1557943881 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease |
| RS1557946006 |
FMO3
|
Health Risk |
Likely pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS1557946448 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 5, primary |
| RS1557948192 |
EPB41
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1557948590 |
EPB41
|
Health Risk |
Pathogenic |
— |
| RS1557956678 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1557959906 |
PKLR
|
Health Risk |
Pathogenic |
— |
| RS1557960039 |
RIT1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 8, Noonan syndrome |
| RS1557960450 |
ASPM
|
Health Risk |
Likely pathogenic |
— |
| RS1557961718 |
SPTA1
|
Health Risk |
Pathogenic |
Pyropoikilocytosis, hereditary |
| RS1557962699 |
RIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 8, Noonan syndrome 1 |
| RS1557962794 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome 8, Noonan syndrome 1 |
| RS1557966012 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS1557967748 |
KCNJ10
|
Health Risk |
Pathogenic |
EAST syndrome, EAST syndrome |
| RS1557977732 |
KCNQ4
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 2A, Autosomal dominant nonsyndromic hearing loss 2A |
| RS1557978852 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1557982817 |
NRAS
|
Health Risk |
Likely pathogenic |
— |
| RS1557988499 |
NEXN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1CC, Hypertrophic cardiomyopathy 20 |
| RS1557990893 |
NEXN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, NEXN-related disorder |
| RS1557995369 |
ATF6
|
Health Risk |
Pathogenic |
— |
| RS1557998187 |
NEXN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1557999318 |
GORAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Geroderma osteodysplastica, Geroderma osteodysplastica |
| RS1558003446 |
ATP1A2
|
Health Risk |
Pathogenic |
Polymicrogyria, Fetal akinesia |
| RS1558004538 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS1558005340 |
ATP1A2
|
Health Risk |
Pathogenic |
Fetal akinesia, respiratory insufficiency |
| RS1558006532 |
GORAB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1558008455 |
ATP1A2
|
Health Risk |
Pathogenic |
Fetal akinesia, respiratory insufficiency |
| RS1558008759 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS1558009266 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Alternating hemiplegia of childhood 1, Migraine |
| RS1558010146 |
ATP1A2
|
Health Risk |
Pathogenic |
Polymicrogyria, Fetal akinesia |
| RS1558014211 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1558014576 |
KCNQ4
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 2A, Autosomal dominant nonsyndromic hearing loss 2A |
| RS1558020021 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1558022158 |
ATF6
|
Health Risk |
Likely pathogenic |
Achromatopsia 7, Achromatopsia 7 |
| RS1558023357 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS1558027212 |
TMCO1
|
Health Risk |
Likely pathogenic |
— |
| RS1558033572 |
PPOX
|
Health Risk |
Likely pathogenic |
Variegate porphyria, Variegate porphyria |
| RS1558033881 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1558036860 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1558037018 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1558038124 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1558038218 |
IRF6
|
Health Risk |
Pathogenic |
Popliteal pterygium syndrome, Orofacial cleft 6 |
| RS1558039371 |
ASH1L
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1558049084 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1558051141 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1558053119 |
EDEM3
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1558054304 |
EDEM3
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, type 2v |
| RS1558056376 |
CACNA1S
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1558056827 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS1558057153 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1558067283 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1558071742 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1558075630 |
CACNA1S
|
Health Risk |
Likely pathogenic |
— |
| RS1558078416 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1558079311 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1558079436 |
DDR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Warburg-cinotti syndrome, Warburg-cinotti syndrome |
| RS1558080206 |
KIF14
|
Health Risk |
Pathogenic |
Microcephaly 20, primary |
| RS1558081384 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1558081605 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1558081624 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Congenital myopathy |
| RS1558081664 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, ACTA1-related disorder |
| RS1558081797 |
ACTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Actin accumulation myopathy, Congenital myopathy 2c |
| RS1558081804 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1558081965 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1558082053 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1558085343 |
KIF14
|
Health Risk |
Likely pathogenic |
— |
| RS1558085770 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS1558087712 |
ARF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Periventricular nodular heterotopia 8, Periventricular nodular heterotopia 8 |
| RS1558087795 |
ARF1
|
Health Risk |
Pathogenic |
Periventricular nodular heterotopia 8, Periventricular nodular heterotopia 8 |
| RS1558088792 |
LAMC2
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 3A |
| RS1558089869 |
LAMC2
|
Health Risk |
Pathogenic |
— |
| RS1558091788 |
NUP133
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 18 |
| RS1558092113 |
PTPN14
|
Health Risk |
Pathogenic |
Lymphedema-posterior choanal atresia syndrome, Lymphedema-posterior choanal atresia syndrome |
| RS1558092158 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS1558092501 |
LAMC2
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa |
| RS1558092897 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS1558095403 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1558095794 |
LAMC2
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 3B |
| RS1558095864 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1558096194 |
EMC1
|
Health Risk |
Pathogenic |
EMC1-related disorder, EMC1-related disorder |
| RS1558098982 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1558102448 |
COA7
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS1558102464 |
COA7
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS1558103974 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1558104145 |
FLVCR1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1558104865 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1558105252 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1558105796 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS1558108130 |
NUP133
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 18 |